WT1 in Colorectal Adenocarcinoma

NCT07778628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-08-21

No results posted yet for this study

Summary

Colorectal carcinoma is a major bublic health problem. It is due to several genetic mutations. Wilms' tumor1 (WT1) gene is a tumor suppressor gene that has been mutated in several human tumors. Detection of WT1 in colorectal carcinoma may provide better future results.

Conditions

Interventions

BIOLOGICAL

immunohistochemical staining with WT1 antibody

4 micrometer thick tissue sections will be stained by anti humal WT1 immunohistochemical antibody.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-15
Primary Completion
2025-12-15
Completion
2026-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07778628 on ClinicalTrials.gov